An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
NCT00291109
·
clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
letrozole 2.5 mg
Sponsor
University of Kansas